Replication Dynamics of Mycobacterium tuberculosis in Chronically Infected Mice
暂无分享,去创建一个
[1] G. Middlebrook. Sterilization of tubercle bacilli by isonicotinic acid hydrazide and the incidence of variants resistant to the drug in vitro. , 1952, American review of tuberculosis.
[2] H. M. Vandiviere,et al. THE TREATED PULMONARY LESION AND ITS TUBERCLE BACILLUS.*: II. THE DEATH AND RESURRECTION , 1956, The American journal of the medical sciences.
[3] R. McCune,et al. FATE OF MYCOBACTERIUM TUBERCULOSIS IN MOUSE TISSUES AS DETERMINED BY THE MICROBIAL ENUMERATION TECHNIQUE , 1956, The Journal of experimental medicine.
[4] W. Mcdermott,et al. THE FATE OF MYCOBACTERIUM TUBERCULOSIS IN MOUSE TISSUES AS DETERMINED BY THE MICROBIAL ENUMERATION TECHNIQUE , 1956, The Journal of experimental medicine.
[5] D. Salkin,et al. The bacteriology of resected tuberculous pulmonary lesions. I. The effect of interval between reversal of infectiousness and subsequent surgery. , 1956, American review of tuberculosis.
[6] J. Sever,et al. Enumeration of viable tubercle bacilli from the organs of nonimmunized and immunized mice. , 1957, American review of tuberculosis.
[7] R. Rees,et al. Analysis of the host-parasite equilibrium in chronic murine tuberculosis by total and viable bacillary counts. , 1961, British journal of experimental pathology.
[8] J. Wallace. The heat resistance of tubercle bacilli in the lungs of infected mice. , 1961, The American review of respiratory disease.
[9] Experimental studies on host-parasite equilibrium in tuberculous infection, in relation to vaccination and chemotherapy. , 1966, Japanese journal of medical science & biology.
[10] W. McDermott. Microbial persistence. , 1969, Harvey lectures.
[11] D. Smith,et al. Host-parasite relationships in experimental airborne tuberculosis. IV. Early events in the course of infection in vaccinated and nonvaccinated guinea pigs. , 1970, The American review of respiratory disease.
[12] I. Orme. A mouse model of the recrudescence of latent tuberculosis in the elderly. , 1988, The American review of respiratory disease.
[13] J. Flynn,et al. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection , 1993, The Journal of experimental medicine.
[14] I. Orme,et al. Disseminated tuberculosis in interferon gamma gene-disrupted mice , 1993, The Journal of experimental medicine.
[15] M. Wootton,et al. The bacterial DNA content of mouse organs in the Cornell model of dormant tuberculosis. , 1995, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[16] T. Wellems,et al. Shared themes of antigenic variation and virulence in bacterial, protozoal, and fungal infections. , 1997, Microbiology and molecular biology reviews : MMBR.
[17] I. Orme,et al. Progression of chronic pulmonary tuberculosis in mice aerogenically infected with virulent Mycobacterium tuberculosis. , 1997, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[18] C. Dye,et al. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. , 1999, JAMA.
[19] F. Kramer,et al. Differential expression of 10 sigma factor genes in Mycobacterium tuberculosis , 1999, Molecular microbiology.
[20] J. Mckinney. In vivo veritas: The search for TB drug targets goes live , 2000, Nature Medicine.
[21] W. El-Sadr,et al. A review of efficacy studies of 6-month short-course therapy for tuberculosis among patients infected with human immunodeficiency virus: differences in study outcomes. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[22] Donna M. Bouley,et al. Dynamic Nature of Host-Pathogen Interactions inMycobacterium marinum Granulomas , 2001, Infection and Immunity.
[23] John Chan,et al. Tuberculosis: Latency and Reactivation , 2001, Infection and Immunity.
[24] Yu-Jin Jung,et al. Expression of Th1-mediated immunity in mouse lungs induces a Mycobacterium tuberculosis transcription pattern characteristic of nonreplicating persistence , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[25] E. Muñoz-Elías,et al. Bacterial Persistence: Strategies for Survival , 2002 .
[26] S. Cole,et al. Comparative and functional genomics of the Mycobacterium tuberculosis complex. , 2002, Microbiology.
[27] A. Sher,et al. Immunology of Infectious Disease , 2002 .
[28] G. Dougan,et al. Chronic bacterial infections: living with unwanted guests , 2002, Nature Immunology.
[29] G. Kaplan,et al. Mycobacterium tuberculosis Growth at theCavity Surface: a Microenvironment with FailedImmunity , 2003, Infection and Immunity.
[30] I. Orme,et al. Materials and Methods Briefdefinitive Report Disseminated Tuberculosis in Interferon 7 Gene-disrupted Mice , 2022 .
[31] Graham R. Stewart,et al. Tuberculosis: a problem with persistence , 2003, Nature Reviews Microbiology.
[32] S. Kaufmann,et al. Cell-wall alterations as an attribute of Mycobacterium tuberculosis in latent infection. , 2003, The Journal of infectious diseases.
[33] Gilla Kaplan,et al. Differential expression of iron-, carbon-, and oxygen-responsive mycobacterial genes in the lungs of chronically infected mice and tuberculosis patients , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[34] D. Ho,et al. HIV-1 dynamics in vivo: implications for therapy , 2003, Nature Reviews Microbiology.
[35] Gregory A. Taylor,et al. Immune Control of Tuberculosis by IFN-γ-Inducible LRG-47 , 2003, Science.
[36] D. Mitchison,et al. The search for new sterilizing anti-tuberculosis drugs. , 2004, Frontiers in bioscience : a journal and virtual library.
[37] J. Pawlotsky. Pathophysiology of hepatitis C virus infection and related liver disease. , 2004, Trends in microbiology.
[38] R. North,et al. Immunity to tuberculosis. , 2003, Annual review of immunology.